GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genflow Biosciences PLC (STU:WQ5) » Definitions » Total Assets

Genflow Biosciences (STU:WQ5) Total Assets : €1.60 Mil (As of Jun. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Genflow Biosciences Total Assets?

Genflow Biosciences's Total Assets for the quarter that ended in Jun. 2024 was €1.60 Mil.

During the past 12 months, Genflow Biosciences's average Total Assets Growth Rate was -47.90% per year.

Total Assets is connected with ROA %. Genflow Biosciences's annualized ROA % for the quarter that ended in Jun. 2024 was -87.15%. Total Assets is also linked to Revenue through Asset Turnover. Genflow Biosciences's Asset Turnover for the quarter that ended in Jun. 2024 was 0.00.

Genflow Biosciences Total Assets Historical Data

The historical data trend for Genflow Biosciences's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genflow Biosciences Total Assets Chart

Genflow Biosciences Annual Data
Trend Dec21 Dec22 Dec23
Total Assets
0.33 3.01 1.24

Genflow Biosciences Semi-Annual Data
Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Total Assets Get a 7-Day Free Trial 3.51 3.01 2.23 1.24 1.60

Genflow Biosciences Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Genflow Biosciences's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Assets=Total Equity (A: Dec. 2023 )+Total Liabilities (A: Dec. 2023 )
=0.843+0.402
=1.25

Genflow Biosciences's Total Assets for the quarter that ended in Jun. 2024 is calculated as

Total Assets=Total Equity (Q: Jun. 2024 )+Total Liabilities (Q: Jun. 2024 )
=1.014+0.583
=1.60

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Genflow Biosciences  (STU:WQ5) Total Assets Explanation

Total Assets is connected with ROA %.

Genflow Biosciences's annualized ROA % for the quarter that ended in Jun. 2024 is

ROA %=Net Income (Q: Jun. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Jun. 2024 ))/ count )
=-1.238/( (1.244+1.597)/ 2 )
=-1.238/1.4205
=-87.15 %

Note: The Net Income data used here is two times the semi-annual (Jun. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Genflow Biosciences's Asset Turnover for the quarter that ended in Jun. 2024 is

Asset Turnover
=Revenue (Q: Jun. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Jun. 2024 ))/ count )
=0/( (1.244+1.597)/ 2 )
=0/1.4205
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Genflow Biosciences Total Assets Related Terms

Thank you for viewing the detailed overview of Genflow Biosciences's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Genflow Biosciences Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genflow Biosciences PLC (STU:WQ5) » Definitions » Total Assets
Comparable Companies
LSE:TCF LSE:CRTX LSE:APTA LSE:ROQ AQSE:INC LSE:VAL LSE:BSFA LSE:NFX LSE:CIZ LSE:PYC VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
GENFF:USA GENF:UK
Address
6 Heddon Street, London, GBR, W1B 4BT
Website
https://www.genflowbio.com
Genflow Biosciences PLC is a preclinical biotechnology company focused on developing innovative biological interventions aimed at tackling the effects of aging, potentially slowing or halting the aging process and reducing the incidence of age-related diseases and thereby increasing life span. The company is also focused on longevity and the development of therapies to counteract the effects of aging and diseases associated with age.

Genflow Biosciences Headlines

No Headlines